Stocktoria
BIOFORCE NANOSCIENCES HOLDINGS, INC. BFNH
OTC · OOTC · stock · Laboratory Analytical Instruments · website · IPO 2005-10-11
BIOFORCE NANOSCIENCES HOLDINGS, INC. financials (annual, from 10-K)
Bars are annual figures from 2017 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | $17,775 | $16,310 | $4,500 |
| Gross profit | — | — | — | — | — | — | $4,360 | $4,665 | $1,255 |
| Operating income | — | — | — | — | — | — | -$46,538 | -$66,740 | -$31,261 |
| Income tax | — | — | — | — | — | — | $0 | $0 | — |
| Net income | -$1.3M | -$490,437 | -$471,953 | -$485,514 | -$501,955 | -$158.4M | -$46,538 | -$67,738 | -$31,261 |
| EPS (diluted) | $-0.04 | $-0.02 | $-0.02 | $-0.02 | — | — | — | — | — |
| Operating cash flow | -$65,150 | -$61,250 | -$46,702 | -$68,389 | -$77,772 | -$80,196 | -$24,383 | -$62,466 | -$25,898 |
| Cash & equivalents | $786 | $862 | $638 | $734 | $11,105 | $39,865 | $52,895 | $29,392 | $14,325 |
| Total assets | $786 | $862 | $638 | $734 | $11,145 | $39,865 | $58,895 | $35,127 | $20,908 |
| Total liabilities | $619,329 | $2.3M | $1.8M | $1.3M | $873,008 | $399,773 | $11,587 | $5,323 | $12,706 |
| Shareholders' equity | -$618,543 | -$2.3M | -$1.8M | -$1.3M | -$861,863 | -$359,908 | $47,308 | $29,804 | $8,202 |
Growth · year-over-year · Revenue CAGR 98.7%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | — | — | — | — | — | — | +9.0% | +262.4% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: SEC EDGAR filings · CIK 0001310488 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.